Archive

Author Archive

BioTime’s (NYSE Amex: BTX) OrthoCyte demonstrates Isolating and Expanding Cartilage-Producing Cells from hESC

April 23rd, 2012 No comments

First demonstration of a scalable source of highly purified and identified progenitor   cells Read more…

Categories: BioTime (AMEX:BTX)

ThermoGenesis (KOOL) Notice of Delisting

April 23rd, 2012 No comments

     Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Read more…

Categories: ThermoGenesis (KOOL)

RegMed Daily, Closing Bell, 4/20/12, gains continue as ASTM starts to show “true value” while expectation get more aggressive with P3 CLI and atherosclerosis indications

April 20th, 2012 No comments

   End of Day, Cause and Effect Read more…

Athersys (ATHX) MultiStem(R) Treatment of Orphan Neurological Disorders and Patent Issuance

April 20th, 2012 No comments

MultiStem administration provides Read more…

RegMed Competitive and Market Intelligence 4/20/12, stocks drifting to gains, volatility tumbles, traders seek cover on triple witching Friday, TGIF

April 20th, 2012 No comments

  The 6 W’s: Who, what, where, when, why and what of it … Read more…

BioTime (NYSE Amex: BTX) Subsidiary LifeMap Sciences to Acquire XenneX,

April 20th, 2012 No comments

     Acquisition will integrate GeneCards^® Read more…

RegMed Daily, Closing Bell, 4/19/12, volatility is here to stay as the market drops and the universe quivers

April 19th, 2012 No comments

    End of Day, Cause and Effect Read more…

RegMed Competitive and Market Intelligence 4/19/12, no longer do we buy on weakness – we sell in strength, stocks keep slumping downward over disappointing economic data and as ever EU concerns

April 19th, 2012 No comments

     The 6 W’s: Who, what, where, when, why and what of it … Read more…

RegMed Daily, Closing Bell, 4/18/12, stocks hover at lows as dislocations drive quiet session

April 18th, 2012 No comments

      End of Day, Cause and Effect Read more…

SynGen Inc. receives $5M Equity Investment

April 18th, 2012 No comments

Venture series A financing from Bay City Capital, LLC Read more…